In our previous studies, transcription factor FOXA2 was confirmed to inhibit EMT in breast cancer cells by regulating the transcription of EMT-related genes and the stable overexpression of FOXA2 abolished breast cancer cell metastasis in vivo (11). This evidence concerns the gene FOXA2 and breast carcinoma.